OSCR

Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study.

Code ↔ Paper

4 matches between paragraphs of the paper and lines of its authors' code, computed by the harvester (lexical-v1). Click a colored paragraph or line to see its counterpart.

3 blocks of code here have a permanent identifier (oscr:b:…), listed with the matches below: citable for good, with a page of its own. Select a match and press Cite to copy it. What a block identifier is.

The 4 matches
  1. [1] § Methods › Sensitivity analyses ↔ AD_Retina_MR_code.R, lines 92 to 131 · score 0.83 · weighted median, Horizontal pleiotropy, weighted mode, MR Egger, Steiger filtering, binary · block oscr:b:FSZCXQBX30XPQ-J · Report a mismatch
  2. [2] § Methods › Study design ↔ AD_Retina_MR_code.R, lines 1 to 44 · score 0.60 · bidirectional MR, sample MR, exposure, GWAS, ocular, variants · block oscr:b:KYVS4H5J623GQ-A · Report a mismatch
  3. [3] § Results › Optic disc area (ODA) influences AD risk but the relationship is probably mediated by refractive error ↔ AD_Retina_MR_code.R, lines 92 to 131 · score 0.57 · MR Egger intercept, horizontal pleiotropy, CI, sensitivity, IVW, AD · block oscr:b:FSZCXQBX30XPQ-J · Report a mismatch
  4. [4] § Results › AD may cause neurodegeneration of the inner retina but the evidence is weak ↔ AD_Retina_MR_code.R, lines 258 to 329 · score 0.50 · horizontal pleiotropy, Steiger filtering, sensitivity, IVW, MR, regression · block oscr:b:K7ED5PW8RBEXS-7 · Report a mismatch

Paper

Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R · 329 lines · 13 KB · no license · 4 matches

  1. ### Script for analysing the causal risk factors of Alzheimer's disease identified from fundal imaging of the eye using bidirectional Mendelian Randomization (MR)
  2. ### TwoSampleMR package was applied for estimating the bidirectional effect between Alzheimer's disease and ocular features,
  3. ### For more information on commands/additional options see: https://mrcieu.github.io/TwoSampleMR/
  4. ## For simplicity, the code of bidirectional MR analysis between Alzheimer's disease and RNFL are provided here
  5. ######################################################################################################################################
  6. # Load packages
  7. ######################################################################################################################################
  8. rm(list=ls(all=TRUE)) #empties your R environment
  9. #Load packages
  10. install.packages("devtools")
  11. library(devtools)
  12. install_github("mrcieu/ieugwasr")
  13. library(ieugwasr)
  14. install_github("MRCIEU/TwoSampleMR")
  15. library(TwoSampleMR)
  16. install.packages("ggplot2")
  17. library(ggplot2)
  18. setwd("PATH_TO_FILE")
  19. ########################################################################################
  20. ########### Estimation of the causal effect of AD on ocular features ####################
  21. ################## AD on RNFL thickness ################################################
  22. #### For the direction of MR casual effect AD to Ocular features, we extracted GWAS summary data of Alzheimer's disease (Kunkle et al, Nature Genetics, 2019)
  23. ## from IEU OpenGWAS project (ID: "ieu-b-2") for the list of variants that showed best level of association after meta analysis of Stage 1 and Stage 2
  24. ## (from the published table 1: https://www.nature.com/articles/s41588-019-0358-2/tables/1). We also copied the column of effect allele from that published table
  25. ## as this column was missing in the summary data of AD in IEU OpenGWAS project.
  26. ############# Read exposure data (AD)
  27. ADx<-read_exposure_data(filename = "Kunkle_publised_gwas_AD_summary_data_with_maf.txt",
  28. snp_col = "MarkerName",
  29. beta_col = "Beta",
  30. se_col = "SE",
  31. effect_allele_col = "Effect_allele",
  32. other_allele_col = "Non_Effect_allele",
  33. eaf_col = "MAF",
  34. pval_col = "Pvalue",
  35. chr_col = "Chromosome",
  36. pos_col = "Position"
  37. )
  38. dim(ADx) # 21 SNPs
  39. #### these columns added to perform Steiger filtering for binary exposure (AD)
  40. ADx$exposure<-"AD"
  41. ADx$prevalence.exposure<-0.1
  42. ADx$ncase.exposure<-21982
  43. ADx$ncontrol.exposure<-41944
  44. ADx$units.exposure<-"log odds"
  45. ### no clumping performed as these variants were reported genome wide significant for AD (P<=5E-08)
  46. ## Source of RNFL summary data: https://www.ebi.ac.uk/gwas/efotraits/OBA_2050111
  47. ### read outcome data (RNFL)
  48. RNFL<-read_outcome_data(snps = ADx$SNP, filename = "GCST90014266_buildGRCh37.tsv", sep = "\t",
  49. snp_col = "variant_id",
  50. beta_col = "beta",
  51. se_col = "standard_error",
  52. effect_allele_col = "effect_allele",
  53. other_allele_col = "other_allele",
  54. eaf_col = "effect_allele_frequency",
  55. pval_col = "p_value",
  56. chr_col = "chromosome",
  57. pos_col = "base_pair_location"
  58. )
  59. #### these columns added to perform Steiger filtering for the outcome (RNFL)
  60. RNFL$outcome<-"RNFL"
  61. RNFL$units.outcome<-rep("SD", nrow(RNFL))
  62. RNFL$samplesize.outcome<-rep(31434, nrow(RNFL))
  63. ## checking if any of the IV are significantly associated to outcome of interst
  64. length(which(RNFL$pvalue.outcome<=5E-8))
  65. #### Harmonization ####################################
  66. dat1 <- harmonise_data(
  67. exposure_dat = ADx,
  68. outcome_dat = RNFL
  69. )
  70. #### Main MR analysis ###############################
  71. mr_results<-mr(dat1, method_list = c("mr_ivw", "mr_egger_regression", "mr_weighted_median", "mr_weighted_mode"))
  72. mr_results
  73. ###### adjusting the beta by multiplying 0.693 for MR with binary exposure ################
  74. mr_results$cbeta<-mr_results$b*0.693
  75. mr_results$cse<-mr_results$se*0.693
  76. mr_results$lcl<- mr_results$cbeta-1.96*mr_results$cse
  77. mr_results$ucl<- mr_results$cbeta+1.96*mr_results$cse
  78. results<-cbind.data.frame(mr_results$outcome,mr_results$exposure,mr_results$nsnp,mr_results$method,mr_results$cbeta,mr_results$lcl, mr_results$ucl,mr_results$pval)
  79. results
  80. names(results)<-c("Outcome", "Exposure", "N_SNPs", "MR_Methods", "Beta", "CI_Lower_Limit", "CI_Upper_Limit", "P_value")
  81. results
  82. #### Measuring the evidence of heterogeneity (significant heterogeneity in the SNP-exposure effects might be suggestive of pleiotropy)
  83. het <- mr_heterogeneity(dat1)
  84. het
  85. ########## measuring the evidence of horizontal pleiotropy (MR egger intercept), A significant intercept suggests signifciant pleiotropy.
  86. pleio <- mr_pleiotropy_test(dat1)
  87. pleio
  88. ######## confidence interval of MR egger inercept
  89. pleio$egger_intercept-1.96*pleio$se
  90. pleio$egger_intercept+1.96*pleio$se
  91. ########### performing single SNP analysis:
  92. ##### default single SNP analyses gives the wald ratio
  93. res_single <- mr_singlesnp(dat1)
  94. ####### leave one out analyses - by defalut uses IVW
  95. res_loo <- mr_leaveoneout(dat1)
  96. ####### performing MR Steiger filtering for additional sensitivity analysis
  97. ##### steiger filtering
  98. dat1_steiger<-steiger_filtering(dat1)
  99. dat1_AD_RNFL_steiger<-subset(dat1_steiger, dat1_steiger$steiger_dir==TRUE)
  100. #### MR analysis after Steiger filtering
  101. mr_results_steiger<-mr(dat1_AD_RNFL_steiger, method_list = c("mr_ivw", "mr_egger_regression", "mr_weighted_median", "mr_weighted_mode"))
  102. mr_results_steiger
  103. ####################################################### Generating MR plots ###################################################
  104. ### Generating a Scatter plot of main MR analysis
  105. p1<-mr_scatter_plot(mr_results,dat1)
  106. p1[[1]]
  107. ggsave(p1[[1]], file="AD_RNFL_scatter_plot.pdf", width=7, height=7)
  108. ### Generating a forest plot of each of the SNP effects
  109. p2<-mr_forest_plot(res_single)
  110. p2[[1]]
  111. ggsave(p2[[1]], file="AD_RNFL_forest_plot.pdf", width=7, height=7)
  112. # Generating a funnel plot to check asymmetry
  113. p3<-mr_funnel_plot(res_single)
  114. p3[[1]]
  115. ggsave(p3[[1]], file="AD_RNFL_main_funnel_plot.pdf", width=7, height=7)
  116. # generating a leave one out plot to test whether any one SNP is driving any pleiotropy or asymmetry in the estimates
  117. p4<-mr_leaveoneout_plot(res_loo)
  118. p4[[1]]
  119. ggsave(p4[[1]], file="AD_RNFL_main_leaveoneout_plot.pdf", width=7, height=7)
  120. ########################################################################################
  121. ########### Estimtation of the causal effect of ocular features on AD ####################
  122. ################## RNFL thickness on AD ################################################
  123. ## Source of RNFL summary data: https://www.ebi.ac.uk/gwas/efotraits/OBA_2050111
  124. ### read exposure data (RNFL)
  125. RNFL<-read_exposure_data(filename = "GCST90014266_buildGRCh37.tsv", sep = "\t",
  126. snp_col = "variant_id",
  127. beta_col = "beta",
  128. se_col = "standard_error",
  129. effect_allele_col = "effect_allele",
  130. other_allele_col = "other_allele",
  131. eaf_col = "effect_allele_frequency",
  132. pval_col = "p_value",
  133. chr_col = "chromosome",
  134. pos_col = "base_pair_location"
  135. )
  136. #### these columns added to perform Steiger filtering for the exposure (RNFL)
  137. RNFL$exposure<-"RNFL"
  138. RNFL$units.exposure<-rep("SD", nrow(RNFL))
  139. RNFL$samplesize.exposure<-rep(31434, nrow(RNFL))
  140. head(RNFL)
  141. ##### selecting the SNPs associated with RNFL with p<5E-08
  142. RNFL1<-subset(RNFL, RNFL$pval.exposure<=5E-8)
  143. #### clumping to get independantly associated SNPs with RNFL thickness
  144. RNFL2<- clump_data(RNFL1)
  145. #### Read outcome data using the IEU OpenGWAS project code: "ieu-b-2"
  146. AD1<-extract_outcome_data(snps = RNFL2$SNP, outcomes = "ieu-b-2")
  147. #### checking if any of the IV are significantly associated to outcome of interst
  148. length(which(AD1$pvalue.outcome<=5E-8))
  149. #### these columns are newly added to perform Steiger filtering for binary outcome (AD)
  150. AD1$prevalence.outcome<-0.1
  151. AD1$ncase.outcome<-21982
  152. AD1$ncontrol.outcome<-41944
  153. AD1$units.outcome<-"log odds"
  154. ##################### extracting the EAF column from the european reference pannel (1000Genome project) as this column is missing in IEU OpendGWAS dataset
  155. ###### eaf column is missing, so need to extract from the 1000 genome project for the European population
  156. data1<-AD1[, c("SNP","chr.outcome", "pos.outcome", "effect_allele.outcome", "other_allele.outcome", "beta.outcome")]
  157. data1$ID<-paste(data1$chr.outcome, data1$pos.outcome, sep = ":")
  158. head(data1)
  159. ### read the 1000Genome file for European ancestry
  160. #library("data.table")
  161. Euro_Genome<-fread("1000Genome_European_referece_snps_maf.txt", sep = "\t")
  162. head(Euro_Genome)
  163. dim(Euro_Genome)
  164. data12<-merge(data1, Euro_Genome, by = "ID")
  165. dim(data12)
  166. head(data12)
  167. ### checking the allele and converting maf accordingly
  168. data12$eaf.outcome<-"NA"
  169. data123 <- within(data12, {
  170. # Check if Effect_Allele matches Minor_Allele
  171. match_effect_minor <- effect_allele.outcome == ALT & other_allele.outcome == REF
  172. # If they do not match, switch the minor allele (ALT is the minor allele and ALTfreq is provided) to effect allele
  173. minor_allele <- ifelse(match_effect_minor, ALT, effect_allele.outcome)
  174. major_allele <- ifelse(match_effect_minor, REF, other_allele.outcome)
  175. # Update Effect_Allele_Frequency from 1-MAF (which is basically ALTfreq) if they didn't match
  176. eaf.outcome <- ifelse(match_effect_minor, eaf.outcome, 1-MAF)
  177. # Update Effect_Allele_Frequency from Minor_Allele_Frequency if they match
  178. eaf.outcome <- ifelse(!match_effect_minor, eaf.outcome, MAF)
  179. })
  180. head(data123)
  181. eafdata<-data123[, c("SNP", "eaf.outcome")]
  182. AD2<-merge(AD1, eafdata, by = "SNP")
  183. #################################################################################################################
  184. #### Harmonization ####################################
  185. dat2 <- harmonise_data(
  186. exposure_dat = RNFL2,
  187. outcome_dat = AD2
  188. )
  189. #### main MR analysis
  190. mr_results<-mr(dat2, method_list = c("mr_ivw", "mr_egger_regression", "mr_weighted_median", "mr_weighted_mode"))
  191. mr_results
  192. #Converting the estimatd beta to odds ratio and estimating 95% confidence interval
  193. or<-generate_odds_ratios(mr_results)
  194. or
  195. orresults<-cbind.data.frame(or$outcome,or$exposure, or$nsnp, or$method, or$or, or$or_lci95, or$or_uci95, or$pval)
  196. orresults
  197. names(orresults)<-c("Outcome", "Exposure", "N_SNPs", "MR_Methods", "OR", "CI_Lower_Limit", "CI_Upper_Limit", "P_value")
  198. orresults
  199. # Runing some sensitivity analyses
  200. # measuring the evidence of heterogeneity in the genetic effects
  201. het <- mr_heterogeneity(dat2)
  202. # Measuring the evidence of horizontal pleiotropy
  203. pleio <- mr_pleiotropy_test(dat2)
  204. ########### performing single SNP analysis:
  205. ##### default single SNP analyses gives the wald ratio
  206. res_single <- mr_singlesnp(dat2)
  207. ####### leave one out analyses - by defalut uses IVW
  208. res_loo <- mr_leaveoneout(dat2)
  209. ####### performing MR Steiger filtering for additional sensitivity analysis
  210. ##### steiger filtering
  211. dat2_steiger<-steiger_filtering(dat2)
  212. dat1_RNFL_AD_steiger<-subset(dat2_steiger, dat2_steiger$steiger_dir==TRUE)
  213. #### MR analysis after Steiger filtering
  214. mr_results_steiger<-mr(dat2_RNFL_AD_steiger, method_list = c("mr_ivw", "mr_egger_regression", "mr_weighted_median", "mr_weighted_mode"))
  215. mr_results_steiger
  216. ####################################################### Generating MR plots ###################################################
  217. ### Generating a Scatter plot of main MR analysis
  218. p1<-mr_scatter_plot(mr_results,dat2)
  219. p1[[1]]
  220. ggsave(p1[[1]], file="RNFL_AD_scatter_plot.pdf", width=7, height=7)
  221. ### Generating a forest plot of each of the SNP effects
  222. p2<-mr_forest_plot(res_single)
  223. p2[[1]]
  224. ggsave(p2[[1]], file="RNFL_AD_forest_plot.pdf", width=7, height=7)
  225. # Generating a funnel plot to check asymmetry
  226. p3<-mr_funnel_plot(res_single)
  227. p3[[1]]
  228. ggsave(p3[[1]], file="RNFL_AD_funnel_plot.pdf", width=7, height=7)
  229. # generating a leave one out plot to test whether any one SNP is driving any pleiotropy or asymmetry in the estimates
  230. p4<-mr_leaveoneout_plot(res_loo)
  231. p4[[1]]
  232. ggsave(p4[[1]], file="RNFL_AD_leaveoneout_plot.pdf", width=7, height=7)
  233. ################ F statistic #########################################
  234. ### selecting the SNPs applied in the main MR analysis
  235. dat_mr<-subset(dat2, dat2$mr_keep==TRUE)
  236. #### defining the vector values from the exposure data
  237. eaf <- dat_mr[,"eaf.exposure"]
  238. b <- dat_mr[,"beta.exposure"]
  239. se <- dat_mr[,"se.exposure"]
  240. p <- dat_mr[,"pval.exposure"]
  241. n <- dat_mr[,"samplesize.exposure"]
  242. snp <- dat_mr[,"SNP"]
  243. # Converting EAF to MAF where necessary
  244. maf <- ifelse(eaf > 0.5, 1 - eaf, eaf)
  245. # Calculating per SNP R2
  246. r2 <- (2 * b^2 * maf * (1 - maf)) / ((2 * b^2 * maf * (1 - maf)) + (se^2 * (2 * n) * maf * (1 - maf)))
  247. # Individual F-stats
  248. k <- 1
  249. F <- r2 * (n - 1 - k) / ((1 - r2) * k)
  250. # Overall R2 and F-stats
  251. k <- length(snp)
  252. all_r2 <- sum(r2)
  253. all_F <- all_r2 * (mean(n) - 1 - k) / ((1 - all_r2) * k)
  254. ########################################################################################################

AD_Retina_MR_code.R at commit 529020f, no license · at the source

Overview

Authors: Humayun Kiser1,2, Ashley Budu-Aggrey3,4, Jessica N. Cooke Bailey5,6,7, Ana Villaplana-Velasco8, Miguel O. Bernabeu9,10, Xiaofan Jiang11,12, Christopher G. Owen13, Jonathan L. Haines6,7, Louis R. Pasquale14, Stuart MacGregor15, Xiaoyi Raymond Gao16, Janey L. Wiggs17, Chen Jiang18, Hélène Choquet18,19, NEIGHBORHOOD consortium, International Glaucoma Genetics Consortium, UK Biobank Eye and Vision Consortium, George Davey Smith3,4, Patrick G. Kehoe1, Neil M. Davies20,21,22, Aimee L. Hanson3,4, Emma L. Anderson3,22, Denize Atan23,24
24 affiliations
  1. Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK
  2. Department of Statistics, Comilla University, Cumilla, Bangladesh
  3. Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, UK
  4. Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK
  5. Center for Health Disparities, Department of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA
  6. Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
  7. Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, OH, USA
  8. Baillie Gifford Pandemic Science Hub, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
  9. Centre for Medical Informatics, Usher Institute, The University of Edinburgh, Edinburgh, Scotland, UK
  10. The Bayes Centre, The University of Edinburgh, Edinburgh, Scotland, UK
  11. UCL Institute of Ophthalmology, London. UK
  12. UCL Great Ormond Street Institute of Child Health, University College London, London, UK
  13. Population Health Research Institute, City St. George’s, University of London, London, UK
  14. Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY USA
  15. QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
  16. Departments of Ophthalmology and Visual Science and Biomedical Informatics, Division of Human Genetics, The Ohio State University, Columbus, OH 43212, USA
  17. Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA
  18. Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA
  19. Department of Health Systems Science Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA
  20. Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, 7034 Trondheim, Norway
  21. Department of Statistical Science, University College London, London, UK
  22. Division of Psychiatry, University College London, London, UK
  23. School of Neuroscience and Psychology, University of Bristol, Bristol, UK
  24. Bristol Eye Hospital, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK
Journal: The journal of prevention of Alzheimer's disease, volume 13, issue 8, article 100635
Dates: received 19 November 2025; accepted 22 June 2026; published online 10 July 2026; in print October 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.tjpad.2026.100635 · PMID 42430965 · PMCID PMC13380462 · OpenAlex W7167930327
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: genetics / omics (modality), human (organism), Alzheimer's / dementia (population)
Keywords: Alzheimer’s disease, Vasculature, Retina, Optic disc, Mendelian randomization
MeSH: Alzheimer Disease*, Mendelian Randomization Analysis*, Genome-Wide Association Study, Humans, Male, Tomography, Optical Coherence (* major topic)
Topic: Glaucoma and retinal disorders (Ophthalmology, Medicine), according to OpenAlex
Funding: Medical Research Council (MC_UU_00032/1&9); Fight for Sight (SGA18_011); Norwegian Research Council (295989); NIH (R01 EY015473, R01 EY022305, R01 EY033829)
Citations: not cited yet (Europe PMC); 32 references in the paper

Abstract

Background: Neurodegeneration in Alzheimer’s disease (AD) is thought to be driven by amyloid-beta and tau deposition in the cerebral vasculature and brain. As the eye is an extension of the central nervous system, this study aimed to determine which neurovascular and neuroretinal changes in the eye are caused by AD rather than associations of the disease.

Methods: Bidirectional two-sample univariable and multivariable Mendelian randomization (MR) methods were applied. Instrumental variables were derived from genome-wide association studies (GWAS) of AD and the following ocular features: thickness measurements of central macula (MT), retinal nerve fibre layer (mRNFL), ganglion cell-inner plexiform layer (mGCIPL), outer nuclear layer (ONL), inner segment layer (IS), and outer segment (OS) from macular region OCT scans; arteriolar tortuosity (AT), venular tortuosity (VT), venular width (VW), fractal dimension (FD), vertical cup-to-disc ratio (VCDR), optic cup area (OCA), and optic disc area (ODA) derived from other imaging methods.

Results: There was strong evidence that genetic liability to AD affected the retinal vasculature by specifically increasing AT (β = 0.007;95%CI=0.002,0.011;p-value=0.005) in UK Biobank participants (n=52,798). AD may influence the mRNFL (β=-0.047,95%CI=-0.119,0.023,p-value=0.18) and mGCIPL (β=-0.061;95%CI=-0.14,0.025,p-value=0.16) of the inner retina and OS layer (β = 0.044;95%CI=-0.0001,0.08;p-value=0.05) but the evidence was weak. Multivariable MR analysis showed that a causal relationship between optic disc area and AD (OR=0.76;95%CI=0.62,0.93,p-value=0.009) was probably mediated by refractive error.

Conclusion: Early cerebrovascular signs of AD may be detected by examination of the eye. Further investigation is required to determine the clinical utility of eye screening for dementia.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repositories

Its files are read in the Code ↔ Paper reader above, with 4 matches between paragraphs and lines of code.

HuKiser/Retinal_features_AD_MR

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Commit: 529020f4cb0e4e3e965b8d8d31a2c7a723bfed77, 14 July 2025
Languages: R (1)
Size: 2 files, 1 script
Software Heritage: not archived
Found in: the text, “Study design”
Holds: README
Not found: license file, CITATION.cff, environment file, tests, continuous integration, documentation
Tools: ggplot2 (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers
  • 27 September 2026: the link answers
2 files

bulik/ldsc

License: GPL-3.0
State: the link answers, verified on 26 October 2026
Evidence: files inventoried
Commit: 2fdeeb3b44379408794154993dbd6101b8946b7e, 16 January 2026
Languages: Python (19), MATLAB (4), Perl (1), R (1)
Size: 1,093 files, 25 scripts
Software Heritage: archived
Found in: the text, “Genetic correlation between ocular traits”
Holds: README, license file, environment (environment.yml, requirements.txt, setup.py), tests
Not found: CITATION.cff, continuous integration, documentation
Tools: NumPy (18 files), pandas (11 files), SciPy (5 files), BEDTools (2 files)
Availability: 2 checks, the latest on 26 October 2026: the link answers
  • 26 October 2026: the link answers
  • 26 September 2026: the link answers
27 files
At the source: github.com/bulik/ldsc/

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 2 repositories of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 26 scripts, each with its path and the digest of its content;
  • 4 matches between paragraphs of the paper and lines of the code (method lexical-v1);
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data sharing statement

The genetic instruments used to perform the MR analyses in this study are provided in the supplementary material. All GWAS summary data used in this study are publicly available or can be provided by the authors upon request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Ashley Budu-Aggrey (0000-0002-8911-2492); Jessica N. Cooke Bailey (0000-0002-4001-8702); Miguel O. Bernabeu (0000-0002-6456-3756); Christopher G. Owen (0000-0003-1135-5977); Janey L. Wiggs (0000-0003-1890-3278); Chen Jiang (0000-0002-0336-4518); George Davey Smith (0000-0002-1407-8314); removed Ashley Budu-Aggrey; Jessica N. Cooke Bailey; Miguel O. Bernabeu; Christopher G. Owen; Janey L. Wiggs; Chen Jiang; George Davey Smith

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 21 authors, 5 keywords, 6 MeSH terms, 4 funders, 32 references.

Cite

This paper

Kiser, H., Budu-Aggrey, A., Bailey, J. N. C., Villaplana-Velasco, A., Bernabeu, M. O., Jiang, X., Owen, C. G., Haines, J. L., Pasquale, L. R., MacGregor, S., Gao, X. R., Wiggs, J. L., Jiang, C., Choquet, H., NEIGHBORHOOD consortium, International Glaucoma Genetics Consortium, UK Biobank Eye and Vision Consortium, Smith, G. D., Kehoe, P. G., Davies, N. M., Hanson, A. L., . . . Atan, D. (2026). Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study. The journal of prevention of Alzheimer's disease, 13(8), 100635. https://doi.org/10.1016/j.tjpad.2026.100635

BibTeX

@article{kiser2026can,
author = {Kiser, Humayun and Budu-Aggrey, Ashley and Bailey, Jessica N. Cooke and Villaplana-Velasco, Ana and Bernabeu, Miguel O. and Jiang, Xiaofan and Owen, Christopher G. and Haines, Jonathan L. and Pasquale, Louis R. and MacGregor, Stuart and Gao, Xiaoyi Raymond and Wiggs, Janey L. and Jiang, Chen and Choquet, Hélène and {NEIGHBORHOOD consortium, International Glaucoma Genetics Consortium, UK Biobank Eye and Vision Consortium} and Smith, George Davey and Kehoe, Patrick G. and Davies, Neil M. and Hanson, Aimee L. and Anderson, Emma L. and Atan, Denize},
title = {{Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study}},
journal = {The journal of prevention of Alzheimer's disease},
year = {2026},
month = jul,
volume = {13},
number = {8},
pages = {100635},
publisher = {Springer Science+Business Media},
issn = {2274-5807},
doi = {10.1016/j.tjpad.2026.100635},
url = {https://doi.org/10.1016/j.tjpad.2026.100635},
pmid = {42430965},
pmcid = {PMC13380462}
}

RIS

TY - JOUR
AU - Kiser, Humayun
AU - Budu-Aggrey, Ashley
AU - Bailey, Jessica N. Cooke
AU - Villaplana-Velasco, Ana
AU - Bernabeu, Miguel O.
AU - Jiang, Xiaofan
AU - Owen, Christopher G.
AU - Haines, Jonathan L.
AU - Pasquale, Louis R.
AU - MacGregor, Stuart
AU - Gao, Xiaoyi Raymond
AU - Wiggs, Janey L.
AU - Jiang, Chen
AU - Choquet, Hélène
AU - NEIGHBORHOOD consortium, International Glaucoma Genetics Consortium, UK Biobank Eye and Vision Consortium
AU - Smith, George Davey
AU - Kehoe, Patrick G.
AU - Davies, Neil M.
AU - Hanson, Aimee L.
AU - Anderson, Emma L.
AU - Atan, Denize
TI - Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study
T2 - The journal of prevention of Alzheimer's disease
J2 - J Prev Alzheimers Dis
PY - 2026
DA - 2026/07/10
VL - 13
IS - 8
SP - 100635
SN - 2274-5807
PB - Springer Science+Business Media
DO - 10.1016/j.tjpad.2026.100635
UR - https://doi.org/10.1016/j.tjpad.2026.100635
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.tjpad.2026.100635",
"type": "article-journal",
"title": "Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study",
"container-title": "The journal of prevention of Alzheimer's disease",
"author": [
{
"family": "Kiser",
"given": "Humayun"
},
{
"family": "Budu-Aggrey",
"given": "Ashley"
},
{
"family": "Bailey",
"given": "Jessica N. Cooke"
},
{
"family": "Villaplana-Velasco",
"given": "Ana"
},
{
"family": "Bernabeu",
"given": "Miguel O."
},
{
"family": "Jiang",
"given": "Xiaofan"
},
{
"family": "Owen",
"given": "Christopher G."
},
{
"family": "Haines",
"given": "Jonathan L."
},
{
"family": "Pasquale",
"given": "Louis R."
},
{
"family": "MacGregor",
"given": "Stuart"
},
{
"family": "Gao",
"given": "Xiaoyi Raymond"
},
{
"family": "Wiggs",
"given": "Janey L."
},
{
"family": "Jiang",
"given": "Chen"
},
{
"family": "Choquet",
"given": "Hélène"
},
{
"literal": "NEIGHBORHOOD consortium, International Glaucoma Genetics Consortium, UK Biobank Eye and Vision Consortium"
},
{
"family": "Smith",
"given": "George Davey"
},
{
"family": "Kehoe",
"given": "Patrick G."
},
{
"family": "Davies",
"given": "Neil M."
},
{
"family": "Hanson",
"given": "Aimee L."
},
{
"family": "Anderson",
"given": "Emma L."
},
{
"family": "Atan",
"given": "Denize"
}
],
"container-title-short": "J Prev Alzheimers Dis",
"volume": "13",
"issue": "8",
"page": "100635",
"DOI": "10.1016/j.tjpad.2026.100635",
"PMID": "42430965",
"PMCID": "PMC13380462",
"ISSN": "2274-5807",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1016/j.tjpad.2026.100635",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
10
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s43587-026-01106-1 [code]
Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomization.
Journal: Nature aging
In common: Alzheimer's / dementia, genetics / omics, 1 reference, 3 authors
[2] doi:10.1136/jnnp-2023-332969 [code]
Genetics impact risk of Alzheimer's disease through mechanisms modulating structural brain morphology in late life.
Journal: Journal of neurology, neurosurgery, and psychiatry
In common: ggplot2, Alzheimer's / dementia, genetics / omics, 4 references, 2 authors
[3] doi:10.1038/s41551-025-01506-5 [code]
Brain-heart-eye axis revealed by multi-organ imaging genetics and proteomics.
Journal: Nature biomedical engineering
In common: BEDTools, pandas, SciPy, 1 other tool, genetics / omics, 5 references
[4] doi:10.1038/s41588-021-00973-1 [code]
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Journal: Nature genetics
In common: BEDTools, pandas, SciPy, 1 other tool, genetics / omics, 2 references, author George Davey Smith
[5] doi:10.1038/s41467-025-61650-z [code]
Machine learning in Alzheimer's disease genetics.
Journal: Nature communications
In common: pandas, SciPy, NumPy, Alzheimer's / dementia, genetics / omics, 3 references, author Patrick G. Kehoe
[6] doi:10.1038/s41380-025-03047-4 [code]
Deciphering the influence of socioeconomic status on brain structure: insights from Mendelian randomization.
Journal: Molecular psychiatry
In common: ggplot2, pandas, SciPy, 1 other tool, genetics / omics, 2 references, author Emma L. Anderson
[7] doi:10.1038/s41467-024-55635-7 [code]
Multi-omic spatial effects on high-resolution AI-derived retinal thickness.
Journal: Nature communications
In common: ggplot2, pandas, SciPy, 1 other tool, genetics / omics, 4 references
[8] doi:10.1038/s41467-024-50309-w [code]
Eye-brain connections revealed by multimodal retinal and brain imaging genetics.
Journal: Nature communications
In common: pandas, SciPy, NumPy, genetics / omics, 5 references
[9] doi:10.1038/s41467-026-71682-8 [code]
GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.
Journal: Nature communications
In common: BEDTools, ggplot2, pandas, 2 other tools, Alzheimer's / dementia, genetics / omics, 4 references
[10] doi:10.1038/s41380-025-03032-x [code]
Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions.
Journal: Molecular psychiatry
In common: pandas, NumPy, Alzheimer's / dementia, genetics / omics, 2 references, author George Davey Smith

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1016/j.tjpad.2026.100635.svg)](https://openscicode.org/badge/doi/10.1016/j.tjpad.2026.100635)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1016/j.tjpad.2026.100635.svg
   :target: https://openscicode.org/badge/doi/10.1016/j.tjpad.2026.100635
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1016/j.tjpad.2026.100635"><img src="https://openscicode.org/badge/doi/10.1016/j.tjpad.2026.100635.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.